Balchem corporation signs definitive agreement to acquire kappa bioscience as

New hampton, n.y., june 14, 2022 (globe newswire) -- balchem corporation (nasdaq:bcpc), a global specialty ingredients company focused on nutrition and health, has signed a definitive agreement to acquire kappa bioscience as (“kappa”), a leading science-based manufacturer of specialty vitamin k2 for the human nutrition industry, headquartered in oslo, norway.
BCPC Ratings Summary
BCPC Quant Ranking